Corpus Intelligence IC Memo — VAN MATRE ENCOMPASS HEALTH REHABILIT 2026-04-26 07:45 UTC
IC Memo — VAN MATRE ENCOMPASS HEALTH REHABILIT
Investment Committee Memorandum | IL | 65 beds | Grade C | EBITDA uplift $2.4M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

VAN MATRE ENCOMPASS HEALTH REHABILIT

CCN 143028 | WINNEBAGO, IL | 65 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

VAN MATRE ENCOMPASS HEALTH REHABILIT is a 65-bed suburban community hospital in WINNEBAGO, IL with $32.0M in net patient revenue and a 8.3% operating margin. The hospital serves a payer mix of 51.6% Medicare, 2.2% Medicaid, and 46.2% commercial.

Thesis: Turnaround. Our ML models identify $2.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 8.3% to 15.7% (+736bps).

Net Revenue HCRIS$32.0M
Current EBITDA COMPUTED$2.7M
Operating Margin COMPUTED8.3%
Occupancy HCRIS84.5%
Revenue / Bed COMPUTED$493K
Net-to-Gross HCRIS68.4%
Distress Probability ML45.9%

2. Market Context & Competitive Position

208
IL Hospitals
-5.3%
State Median Margin
58
Comparable Hospitals

IL has 208 Medicare-certified hospitals with a median operating margin of -5.3%. The target's margin of 8.3% places it above the state median. Among 58 size-comparable peers (32-130 beds), the median margin is -7.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (32-130), prioritizing same-state peers. 58 hospitals in the comp set.

HospitalStateBedsRevenueMargin
VAN MATRE ENCOMPASS HEALTH REH (Target)IL65$32.0M8.3%
MIDWESTERN REGIONAL MEDICAL CEIL73$1.38B80.5%
NORTHWESTERN LAKE FOREST HOSPIIL124$494.3M-13.8%
SARAH BUSH LINCOLN HEALTH CENTIL100$448.6M-18.1%
KISHWAUKEE COMMUNITY HOSPITALIL98$355.3M25.5%
CGH MEDICAL CENTERIL95$247.1M-7.6%
SSM HEALTH GOOD SAMARITAN HOSPIL111$214.8M1.5%
MORRIS HOSPITALIL89$210.8M1.7%
ADVENTIST BOLINGBROOK HOSPITALIL110$199.3M-5.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.4M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$673K+210bp18mo
Cost to Collect4.5%2.5%$641K+200bp12mo
Denial Rate Reduction12.0%6.5%$634K+198bp12mo
A/R Days Reduction5200.0%3800.0%$390K+122bp9mo
Clean Claim Rate88.0%96.0%$20K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$673K
Cost to Collect
$641K
Denial Rate Reduction
$634K
A/R Days Reduction
$390K
Clean Claim Rate
$20K
Total EBITDA Uplift$2.4M
Current EBITDA$2.7M
+ RCM Uplift+$2.4M
Pro Forma EBITDA$5.0M
Current Margin8.3%
Pro Forma Margin15.7%
WC Released (1x)$1.2M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$4.1M$41.2M10.02x58.6%
Base (11x exit)10.0x11.0x$4.1M$46.7M11.35x62.5%
Bull Case9.0x11.0x$3.7M$55.8M15.08x72.0%
Bull (12x exit)9.0x12.0x$3.7M$62.0M16.74x75.7%
Bear Case11.0x10.0x$4.5M$28.1M6.21x44.1%
Bear (11x exit)11.0x11.0x$4.5M$32.4M7.16x48.2%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 58 hospitals with 32-130 beds
  • Same-state prioritization (n=59)
  • Comp margins: P25=-19.9% / P50=-7.8% / P75=3.6%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.